Effect and Safety of Orelabrutinib and Lenalidomide Plus R-mini CDOP in Relapsed/Refractory Aggressive B-cell Non-Hodgkin Lymphoma
TURKISH JOURNAL OF HEMATOLOGY(2023)
关键词
Relapsed/refractory aggressive B-cell lymphoma,Orelabrutinib,Lenalidomide,R-mini CDOP
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要